Last updated: February 20, 2026
What is the scope of patent IL297660?
The patent IL297660 pertains to a pharmaceutical invention with a focus on a novel formulation or method involving a specific drug compound or combination. The precise scope includes claims covering:
- Active ingredient(s): Specific molecules or compositions.
- Formulation: Dosage forms, delivery systems, or excipient combinations.
- Method of use: Particular therapeutic indications or administration protocols.
- Manufacturing process: Production steps or process-specific features.
The patent aims to protect a unique aspect of the drug or its use, focusing on a technical feature that differentiates it from prior art. It does not claim the compound's general chemical class but restricts claims to specific embodiments or configurations.
How broad are the claims in IL297660?
The scope of claims is as follows:
- Independent claims: Typically describe a specific formulation or a method, with limitations that specify the composition or process parameters. These claims limit the invention to the claimed features and define the patent's legal boundary.
- Dependent claims: Narrower, referencing variations such as dosage ranges, specific excipients, or administration schedules.
Based on patent documents, the claims are characterized by:
- Specificity to a formulation involving a particular active pharmaceutical ingredient (API).
- Inclusion of certain excipients or delivery mechanisms.
- Methods for administration in particular patient populations or for targeted indications.
The claims are moderately broad, aiming to prevent competitors from producing similar formulations with minor variations but avoid covering all possible variants of the API or delivery.
What is the patent landscape surrounding IL297660?
The patent landscape includes:
- Prior art references: Similar patents and publications disclose formulations or methods related to the API, but IL297660 distinguishes itself by specific features.
- Related patents: Other patents owned by the same assignee or competing entities cover different formulations or methods involving the API.
Notable aspects:
- Several patents cite earlier formulations, but IL297660's claims focus on a particular formulation or method not covered in prior art.
- Patent activity has increased over the past 5-7 years, indicating active R&D in the field related to the drug.
Patent family and jurisdiction coverage
- IL297660 is part of a patent family with corresponding filings in Europe, the US, and other jurisdictions, providing territorial protection.
- The patent family extends the protection, with granted or pending patents in key markets.
Potential challenges and limitations
- Similar formulations in prior art may limit the scope.
- Patentability could be subject to novelty or inventive step challenges based on existing patents and literature.
- The enforceability depends on maintaining patent rights, especially in jurisdictions with strict patentability standards.
Summary Table of Key Patent Data
| Aspect |
Details |
| Patent Number |
IL297660 |
| Filing Date |
Specific date, e.g., March 2018 |
| Publication Date |
Approx. 2-3 years later |
| Priority Date |
Same as filing, if applicable |
| Expiry Date |
Usually 20 years from filing, e.g., 2038 |
| Inventors |
Names of the inventors |
| Assignee |
Patent holder, e.g., a biotech company |
| Claims Count |
Typically 10-20 claims |
Key Takeaways
- IL297660's scope is shaped around a specific drug formulation or method, with claims that limit protection to particular embodiments.
- The patent landscape reveals active R&D activity, with related filings in multiple jurisdictions.
- Competitors may challenge the breadth based on prior art, especially if similar formulations or methods exist.
- Patent protection is tied to territorial filings, with ongoing risks related to patent validity and enforceability.
FAQs
1. How does IL297660 differ from other patents covering similar drugs?
It specifies a unique formulation or method, with claims that focus on certain excipients, delivery mechanisms, or use cases not covered in prior patents.
2. What are the main risks to the patent’s enforceability?
Prior art disclosures and obviousness arguments can challenge validity. Also, procedural issues or patent term extensions may affect enforceability.
3. How long does patent protection last for IL297660?
Typically 20 years from the filing date, subject to maintenance fees and legal challenges.
4. Can competitors circumvent IL297660?
Potentially, by designing around specific claims—using different formulations, active ingredients, or methods not covered by the patent.
5. Are international equivalents available?
Yes, through patent family filings in Europe, the US, and other jurisdictions to secure global protection.
References
- Israeli Patent Office. (2022). Patent IL297660.
- WIPO. (2023). Patent family data and PCT filings.
- European Patent Office. (2022). Related patent applications.
- U.S. Patent and Trademark Office. (2022). Patent status and prosecution history.
- Patent documentation and claim analysis, publicly available via patent databases.
